EC FP6 funding directed at device industry:
This article was originally published in Clinica
Executive Summary
Imaging, radiotherapy, clinical trials for breast cancer and leukaemia, and the link between genomics and cancer have been selected by the European Commission among the first group of 19 projects to receive some E100m ($116m) of funding in the context of its Sixth Framework Programme (FP6 2002-2006). The projects will also aim to create bio-banks and cancer registers. A key focus, the Commission says, will be to "quickly turn the advances in cancer research into practical and meaningful early stage diagnoses and therapies for patients". The projects respond to the challenge of creating a European Research Area, according to the Commission, and were chosen to reinforce European excellence and promote research in the fight against cancer.